About
Specialty Pharmaceuticals
Areas of Focus
Categories
Small Molecule PharmaceuticalGeneric Drug
Team (23)
Albert Dahouk
Chief Information Officer
Covis Pharma
team_member
Alexis Heinen
Partner, Cross Ocean Partners
Covis Pharma
team_member
Andrew Teehan
Interim General Counsel
Covis Pharma
executive
Chad Collins
Vice President & General Manager, U.S. Business
Covis Pharma
executive
Christine Poulin
President, North America & General Manager of Canada
Covis Pharma
executive
Claude Noesen
Independent Non-Executive Fund Director
Covis Pharma
board_member
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
495
By Phase
PHASE3: 1PHASE2: 1PHASE4: 1
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT04377711Lead Sponsor
A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients
PHASE3Completed
400 participants
Started: Jun 8, 2020 · Completed: Jan 5, 2021
NCT02688270Lead Sponsor
Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon
PHASE2Completed
65 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2016
NCT00458835Lead Sponsor
Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)
PHASE4Completed
30 participants
Started: Apr 30, 2007 · Completed: Apr 30, 2008
Locations (1)
Headquarters
Zug, Switzerland
Map
Loading map...